That means a person has to have a BMI of 30 or greater, or of 27 or greater with a concomitant risk factor, such as hypertension or prediabetes
If latter, working with therapist to process this may be valuable before making decisions
So a bunch of different scientists started testing it in Petri dishes and in animals, and it turns out GLP-1 increases insulin release and lowers blood sugar and slows the rate the stomach empties out and makes people feel more full and eat less, exactly the things that could help treat type two diabetes
Additionally, systemic administration of VIP can lead to cardiovascular and gastrointestinal side effects, such as a significant decrease in blood pressure (7)
Wadhwa V, Mehta D, Jobanputra Y, Lopez R, Thota PN, Sanaka MR
10.1016/j.bbrc.2019.05.137 164 MercadanteC